Envestnet Asset Management Inc. boosted its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 7.1% in the second quarter, HoldingsChannel.com reports. The firm owned 117,549 shares of the pharmacy operator’s stock after purchasing an additional 7,807 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Walgreens Boots Alliance were worth $7,055,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors also recently added to or reduced their stakes in the company. Sei Investments Co. boosted its position in Walgreens Boots Alliance by 100.9% during the 2nd quarter. Sei Investments Co. now owns 349,451 shares of the pharmacy operator’s stock valued at $20,970,000 after purchasing an additional 175,551 shares during the period. Piedmont Investment Advisors LLC boosted its position in Walgreens Boots Alliance by 12.7% during the 2nd quarter. Piedmont Investment Advisors LLC now owns 198,734 shares of the pharmacy operator’s stock worth $11,927,000 after acquiring an additional 22,356 shares during the period. Bailard Inc. acquired a new position in Walgreens Boots Alliance during the 2nd quarter worth $290,000. Prentiss Smith & Co. Inc. boosted its position in Walgreens Boots Alliance by 1,125.9% during the 2nd quarter. Prentiss Smith & Co. Inc. now owns 120,913 shares of the pharmacy operator’s stock worth $7,257,000 after acquiring an additional 111,050 shares during the period. Finally, Wealth Advisors of Tampa Bay LLC boosted its position in Walgreens Boots Alliance by 5.9% during the 2nd quarter. Wealth Advisors of Tampa Bay LLC now owns 24,867 shares of the pharmacy operator’s stock worth $1,523,000 after acquiring an additional 1,390 shares during the period. Institutional investors and hedge funds own 61.99% of the company’s stock.
In other news, COO Ornella Barra acquired 1,700,000 shares of the company’s stock in a transaction dated Monday, July 16th. The shares were bought at an average price of $65.15 per share, with a total value of $110,755,000.00. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total value of $180,548.64. Following the completion of the sale, the director now directly owns 10,943 shares in the company, valued at approximately $722,128.57. The disclosure for this sale can be found here. 14.80% of the stock is currently owned by insiders.
WBA opened at $68.19 on Friday. Walgreens Boots Alliance Inc has a one year low of $59.07 and a one year high of $83.89. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.47 and a current ratio of 0.93. The firm has a market capitalization of $67.51 billion, a PE ratio of 11.63, a PEG ratio of 1.03 and a beta of 1.09.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, June 28th. The pharmacy operator reported $1.53 EPS for the quarter, topping the Zacks’ consensus estimate of $1.47 by $0.06. Walgreens Boots Alliance had a return on equity of 21.22% and a net margin of 3.36%. The company had revenue of $34.33 billion for the quarter, compared to the consensus estimate of $34.15 billion. During the same quarter in the previous year, the business earned $1.33 EPS. The company’s quarterly revenue was up 14.0% compared to the same quarter last year. research analysts forecast that Walgreens Boots Alliance Inc will post 5.97 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 12th. Stockholders of record on Monday, August 20th will be paid a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.58%. The ex-dividend date is Friday, August 17th. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.40. Walgreens Boots Alliance’s payout ratio is currently 34.51%.
A number of brokerages have issued reports on WBA. BidaskClub upgraded Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, August 21st. Zacks Investment Research lowered Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Wednesday, June 20th. Cowen lowered Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating and set a $104.00 price target for the company. in a research report on Monday, July 23rd. ValuEngine lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Tuesday, May 22nd. Finally, Leerink Swann reduced their price target on Walgreens Boots Alliance from $75.00 to $70.00 and set a “market perform” rating for the company in a research report on Wednesday, May 23rd. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $77.22.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Featured Article: Hedge Funds
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.